GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » Net Cash per Share

PRVA (Privia Health Group) Net Cash per Share : $-0.08 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Privia Health Group's Net Cash per Share for the quarter that ended in Dec. 2024 was $-0.08.

The historical rank and industry rank for Privia Health Group's Net Cash per Share or its related term are showing as below:

During the past 7 years, the highest Price-to-Net-Cash Ratio of Privia Health Group was 48.32. The lowest was 45.39. And the median was 46.86.

PRVA's Price-to-Net-Cash is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 7.445
* Ranked among companies with meaningful Price-to-Net-Cash only.

Privia Health Group Net Cash per Share Historical Data

The historical data trend for Privia Health Group's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Privia Health Group Net Cash per Share Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Cash per Share
Get a 7-Day Free Trial -0.94 0.57 0.47 -0.41 -0.08

Privia Health Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.41 -0.87 -0.79 -0.91 -0.08

Competitive Comparison of Privia Health Group's Net Cash per Share

For the Health Information Services subindustry, Privia Health Group's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group's Price-to-Net-Cash Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Privia Health Group's Price-to-Net-Cash falls into.


;
;

Privia Health Group Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Privia Health Group's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as

Net Cash per Share (A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(491.149-452.336-48.264)/120.309
=-0.08

Privia Health Group's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as

Net Cash per Share (Q: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(491.149-452.336-48.264)/120.309
=-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Privia Health Group  (NAS:PRVA) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Privia Health Group Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Privia Health Group's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Privia Health Group Business Description

Traded in Other Exchanges
N/A
Address
950 North Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Executives
David Mountcastle officer: Chief Financial Officer 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Parth Mehrotra officer: President and COO 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler director 1215 5TH AVE N,, NASHVILLE TN 37208
Thomas A Mccarthy director 1601 CHESTNUT STREET, SHAREHOLDER SERVICES TL18Y, PHILADELPHIA PA 19192
Thomas Bartrum officer: EVP, General Counsel 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Matthew Shawn Morris director, officer: Chief Executive Officer 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
William M Sullivan director ONE PENN PLAZA, SUITE 5300, NY NY 10119
Pamela O Kimmet director 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein director 200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p. 10 percent owner 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c. 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey B Butler director 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203